The Greenbrier Companies, Inc. faces cyclical headwinds, weaker manufacturing, and one-time earnings. Click for this look at ...
Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback